TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+3.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.91B
AUM Growth
+$2.91B
(+2.1%)
Cap. Flow
+$57.4M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
226
New
26
Increased
31
Reduced
49
Closed
30
Top Buys
| 1 |
Elevance Health
ELV
|
$45.8M |
| 2 |
Abbott
ABT
|
$37.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$31.8M |
| 4 |
Moderna
MRNA
|
$29.3M |
| 5 |
Gilead Sciences
GILD
|
$26.5M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$59.8M |
| 2 |
Becton Dickinson
BDX
|
$21.5M |
| 3 |
Humana
HUM
|
$19.1M |
| 4 |
Bio-Techne
TECH
|
$16.8M |
| 5 |
NovoCure
NVCR
|
$15.2M |
Sector Composition
| 1 | Healthcare | 95.75% |
| 2 | Real Estate | 2.99% |
| 3 | Industrials | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DexCom
DXCM
$30.9B
| $26.8M | 0.92% |
74,643
| – | – |
|
27
ResMed
RMD
$39.4B
| $25.7M | 0.88% |
132,344
| – | – |
|
28
Pfizer
PFE
$141B
| $25.6M | 0.88% |
705,259
| – | – |
|
29
Labcorp
LH
$22.8B
| $25.4M | 0.87% |
99,580
+34,977
| +54% | +$8.92M |
|
30
Exelixis
EXEL
$9.95B
| $24.9M | 0.86% |
1,100,920
-155,600
| -12% | -$3.52M |
|
31
McKesson
MCK
$85.9B
| $24.6M | 0.85% |
125,948
-4,500
| -3% | -$878K |
|
32
Guardant Health
GH
$8.11B
| $24.2M | 0.83% |
158,727
+40,875
| +35% | +$6.24M |
|
33
Steris
STE
$23.9B
| $24.1M | 0.83% |
126,779
| – | – |
|
34
Dentsply Sirona
XRAY
$2.77B
| $22.4M | 0.77% |
351,427
-14,500
| -4% | -$925K |
|
35
Exact Sciences
EXAS
$9.33B
| $22M | 0.76% |
167,302
+103,800
| +163% | +$13.7M |
|
36
Alnylam Pharmaceuticals
ALNY
$58.6B
| $21.9M | 0.75% |
154,902
-19,992
| -11% | -$2.82M |
|
37
Neurocrine Biosciences
NBIX
$13.5B
| $20.7M | 0.71% |
212,891
-81,343
| -28% | -$7.91M |
|
|
SYNH
38
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $20.7M | 0.71% |
272,647
+77,511
| +40% | +$5.88M |
|
39
Edwards Lifesciences
EW
$47.7B
| $20M | 0.69% |
238,755
-26,200
| -10% | -$2.19M |
|
40
Novavax
NVAX
$1.2B
| $19.1M | 0.66% |
105,176
+28,591
| +37% | +$5.18M |
|
|
ALLK
41
DELISTED
Allakos
ALLK
| $18.8M | 0.65% |
163,645
+32,708
| +25% | +$3.75M |
|
42
CRISPR Therapeutics
CRSP
$4.82B
| $18.4M | 0.63% |
150,958
+74,736
| +98% | +$9.11M |
|
43
argenx
ARGX
$44.2B
| $17.7M | 0.61% |
64,344
+2,657
| +4% | +$732K |
|
44
AstraZeneca
AZN
$255B
| $17.1M | 0.59% |
344,333
| – | – |
|
45
Idexx Laboratories
IDXX
$50.7B
| $17M | 0.59% |
34,814
| – | – |
|
|
ALXN
46
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $16.9M | 0.58% |
110,693
-391,249
| -78% | -$59.8M |
|
47
CVS Health
CVS
$93B
| $16.6M | 0.57% |
219,995
| – | – |
|
48
Iovance Biotherapeutics
IOVA
$800M
| $16.5M | 0.57% |
520,595
+249,522
| +92% | +$7.9M |
|
|
PRAH
49
DELISTED
PRA Health Sciences, Inc.
PRAH
| $15.9M | 0.55% |
103,943
-71,895
| -41% | -$11M |
|
50
Intuitive Surgical
ISRG
$158B
| $15.7M | 0.54% |
21,296
| – | – |
|